BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 19141144)

  • 1. Recent clinical findings with memantine should not mean that the idea of neuroprotection in glaucoma is abandoned.
    Osborne NN
    Acta Ophthalmol; 2009 Jun; 87(4):450-4. PubMed ID: 19141144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. History of neuroprotection and rationale as a therapy for glaucoma.
    Levin LA; Peeples P
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S11-4. PubMed ID: 18284310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.
    Zhong L; Bradley J; Schubert W; Ahmed E; Adamis AP; Shima DT; Robinson GS; Ng YS
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1212-8. PubMed ID: 17325165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of ganglion "cell death" in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria.
    Osborne NN
    Prog Brain Res; 2008; 173():339-52. PubMed ID: 18929120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
    Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of brain-derived neurotrophic factor and LINGO-1 fusion protein on long-term survival of retinal ganglion cells in chronic glaucoma.
    Fu QL; Li X; Yip HK; Shao Z; Wu W; Mi S; So KF
    Neuroscience; 2009 Aug; 162(2):375-82. PubMed ID: 19422885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saving the nerve from glaucoma: memantine to caspaces.
    Naskar R; Vorwerk CK; Dreyer EB
    Semin Ophthalmol; 1999 Sep; 14(3):152-8. PubMed ID: 10790579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cell-based approaches for neuroprotection in glaucoma.
    Lebrun-Julien F; Di Polo A
    Optom Vis Sci; 2008 Jun; 85(6):417-24. PubMed ID: 18521011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma.
    Seki M; Lipton SA
    Prog Brain Res; 2008; 173():495-510. PubMed ID: 18929130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contemporary possibilities and perspectives in the treatment of glaucoma].
    Czepita D
    Ann Acad Med Stetin; 2005; 51(1):27-31. PubMed ID: 16496599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotection in glaucoma: recent and future directions.
    Danesh-Meyer HV
    Curr Opin Ophthalmol; 2011 Mar; 22(2):78-86. PubMed ID: 21252670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Retinal ganglion cells death in glaucoma--mechanism and potential treatment. Part I].
    Rokicki W; Dorecka M; Romaniuk W
    Klin Oczna; 2007; 109(7-9):349-52. PubMed ID: 18260296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of memantine in progressive glaucoma. Case report].
    Schröder A; Erb C
    Klin Monbl Augenheilkd; 2002 Jul; 219(7):533-6. PubMed ID: 12195321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of neuroprotection in glaucoma treatment.
    Osborne NN; Chidlow G; Nash MS; Wood JP
    Curr Opin Ophthalmol; 1999 Apr; 10(2):82-92. PubMed ID: 10537768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glaucoma neuroprotection--how far is it from a dream to reality].
    Ge J
    Zhonghua Yan Ke Za Zhi; 2008 May; 44(5):385-7. PubMed ID: 18953889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological aspects in glaucoma].
    Istrate B
    Oftalmologia; 2010; 54(2):44-7. PubMed ID: 20827910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroprotection in glaucoma].
    Stefan C; Melinte-Dumitrica D; Selaru D; Musat O; Zemba M; Serghiescu I
    Oftalmologia; 2010; 54(2):7-10. PubMed ID: 20827905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glaucoma: Focus on mitochondria in relation to pathogenesis and neuroprotection.
    Osborne NN; Núñez-Álvarez C; Joglar B; Del Olmo-Aguado S
    Eur J Pharmacol; 2016 Sep; 787():127-33. PubMed ID: 27090928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of memantine and galantamine given separately or in association, on memory and hippocampal neuronal loss after transient global cerebral ischemia in gerbils.
    Lorrio S; Negredo P; Roda JM; García AG; López MG
    Brain Res; 2009 Feb; 1254():128-37. PubMed ID: 19103181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.